ZIA KHAN: Open Payments
NPI 1386633543 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,338 in 87 payments from 21 companies in 2025. Trend: 2023 $1,675 · 2024 $2,106 · 2025 $2,338
Food & beverage: $2,169Education: $169
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 21 | $690 |
| Siemens Medical Solutions USA, Inc. | 3 | $276 |
| Merck Sharp & Dohme LLC | 13 | $262 |
| Amgen Inc. | 16 | $200 |
| Novartis Pharmaceuticals Corporation | 7 | $147 |
| Philips North America LLC | 3 | $94 |
| CVRx, Inc. | 3 | $93 |
| Boston Scientific Corporation | 2 | $78 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $65 |
| Bard Peripheral Vascular, Inc. | 2 | $62 |
Products named: UPTRAVI, OPSUMIT, WINREVAIR, REPATHA, LEQVIO, NAEOTOM Alpha, OPSYNVI, Biograph mCT X-4R.
Industry payments across NV — which companies pay providers there.
